Addex Therapeutics (ADXN) Cash & Equivalents Growth (3y) (2021 - 2025)
Addex Therapeutics (ADXN) Cash & Equivalents Growth (3y) (2021 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash & Equiv. Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
24.73% |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
-40.88% |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
-28.55% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
21.66% |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
-16.07% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Addex Therapeutics |
1.23 Bn |
1.23 Bn |
- |
-34.28% |
| Date | Value |
|---|
| Dec 31, 2025 |
-34.28% |
| Sep 30, 2025 |
-49.48% |
| Jun 30, 2025 |
-42.53% |
| Mar 31, 2025 |
-47.87% |
| Dec 31, 2024 |
-44.42% |
| Sep 30, 2024 |
-99.40% |
| Jun 30, 2024 |
5,829.64% |
| Mar 31, 2024 |
-99.40% |
| Dec 31, 2023 |
-40.49% |
| Sep 30, 2023 |
-99.39% |
| Jun 30, 2023 |
-99.38% |
| Mar 31, 2023 |
-38.67% |
| Dec 31, 2022 |
-39.03% |
| Sep 30, 2022 |
-20.55% |
| Jun 30, 2022 |
-16.59% |
| Mar 31, 2022 |
-17.16% |
| Dec 31, 2021 |
-11.17% |
